Picture of Subex logo

SUBEXLTD Subex News Story

0.000.00%
in flag iconLast trade - 00:00
TechnologySpeculativeSmall CapFalling Star

REG - Subex Limited - Subex Limited 3rd Quarter Results <Origin Href="QuoteRef">SUBX.NS</Origin>

RNS Number : 9916V
Subex Limited
03 February 2017

February 03, 2017

To

TheLondon Stock Exchange

10PaternosterSquare

London

EC4M 7LS

DearSirs,

Sub: Outcome of the Board Meeting held on February 03, 2017

Please be informed that the agenda item stated hereunder was discussed and approved at the Board Meeting held on February 03, 2017 at Mumbai:

Unaudited standalone and consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2016.

Please find enclosed:

The consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2016.

We request you to take the aforesaid notification on record.

Yours faithfully

For and on behalfofSubexLimited

Ganesh K V

Chief Financial Officer, Global Head -Legal and CompanySecretary

Subex Limited

Registered office: RMZ Ecoworld, Outer Ring Road, Devarabisanahalli, Bangalore - 560 037

Statement of Consolidated Unaudited Results for the quarter and nine months ended December 31, 2016








(Rs in Lakhs)






Consolidated






3 months ended

Preceding 3

Corresponding 3

Year to date figures for the nine




months ended

months ended



Particulars

December 31,

months ended December 31,



September 30,

December 31,

















2016

2016

2015

2016

2015




Unaudited

Unaudited

Unaudited

Unaudited

Unaudited




(refer note 4)

(refer note 4)








1

Income from operations








Net sales/ income from operations

9,578

8,336

8,055

26,248

23,320











Total income from operations (net)

9,578

8,336

8,055

26,248

23,320


2

Expenses







(a)

Cost of hardware, software and support charges

194

44

84

490

180


(b)

Employee benefits expense (refer note 10)

4,047

4,175

3,738

12,289

11,772


(c)

Other expenditure

2,891

2,689

2,403

8,046

6,863


(d)

Depreciation and amortisation expense

127

117

110

356

317


(e)

Exchange fluctuation (gain)/loss (net)

(316)

(211)

(409)

(1,345)

1,486











Total expenses

6,943

6,814

5,926

19,836

20,618


3








Profit from operations before other income and

2,635

1,522

2,129

6,412

2,702



finance costs (1-2)







4

Other income (refer note 7)

394

268

28

891

112


5








Profit from ordinary activities before finance costs

3,029

1,790

2,157

7,303

2,814



(3+4)







6

Finance costs







(a)

Interest on FCCBs

126

128

905

388

3,268


(b)

Interest on term loan

96

167

245

464

720


(c)

Other finance costs

234

223

383

680

1,035











Total finance costs

456

518

1,533

1,532

5,023


7








Profit/(loss) from ordinary activities before tax (5-6)

2,573

1,272

624

5,771

(2,209)


8

Tax expense (net)

318

298

254

724

1,091


9








Net profit/ (loss) for the period (7-8)

2,255

974

370

5,047

(3,300)


10

Other comprehensive income, net of taxes

(561)

(244)

(544)

(1,651)

(876)


11








Total comprehensive income (9+10)

1,694

730

(174)

3,396

(4,176)


12

Paid up share capital (face value of Rs 10)

50,691

50,691

42,175

50,691

42,175


13

Earnings/(loss) per share (of Rs 10/- each) (not annualised







in case of the interim periods):







(a)

- Basic

0.44

0.19

0.11

1.00

(1.34)


(b)

- Diluted

0.44

0.19

0.11

1.00

(1.34)










Notes:

1 The above results have been reviewed by the Audit Committee and approved by the Board of Directors in their meeting held on February 03, 2017.

2 The financial results of Subex Limited (Standalone Information):






(Rs in Lakhs)


3 months ended

Preceding 3

Corresponding 3

Year to date figures for the nine


months ended

months ended

Particulars

December 31,

months ended December 31,

September 30,

December 31,






2016

2016

2015

2016

2015


Unaudited

Unaudited

Unaudited

Unaudited

Unaudited


(refer note 4)

(refer note 4)





Net sales/ income from operations

8,690

7,505

7,618

23,868

21,301

Profit/(loss) from ordinary activities before tax

1,763

401

459

2,810

(2,786)

Profit/(loss) from ordinary activities after tax

1,712

321

290

2,670

(3,303)

3 The financial results have been prepared in accordance with the recognition and measurement principles laid down in Indian Accounting Standards ("Ind AS") 34 on Interim Financial Reporting prescribed under section 133 of the Companies Act, 2013, read with relevant rules thereunder and in terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and SEBI Circular No. CIR/CFD/FAC/62/2016 dated July 5, 2016.

The Company has opted to avail relaxation provided by SEBI vide the aforesaid circular dated July 5, 2016 in respect of disclosure requirements for corresponding figures of earlier periods. Accordingly, the financial results for the year ended March 31, 2016 has not been presented. The reserves (excluding revaluation reserve), as per the balance sheet of the previous accounting year not being mandatory, have not been presented.

4 Consequent to transition from the Previous GAAP to Ind AS, the reconciliation of profit/loss after tax is provided below for the corresponding 3 months ended December 31, 2015 and year to date figures ('YTD') for the nine months ended December 31, 2015:







(Rs in Lakhs)






Corresponding 3

YTD nine months






months ended


Particulars



ended December




December 31,






31, 2015






2015








Net profit under previous GAAP



5,938

7,023


Add/(less): Ind-AS adjustments income/(loss):






(i) Measurement of Foreign Currency Convertible Bonds ('FCCBs') at fair value






(a) Impact on finance cost due to effective interest rate and transfer of interest no longer payable to retained earnings

(5,165)

(8,926)


on conversion of FCCBs into equity shares






(b) Impact on foreign exchange due to change in carrying value of FCCBs and related account balances and transfer

(482)

(1,428)


of exchange gain to retained earnings on conversion of FCCBs into equity shares





(ii) Impact of deferral of revenue pertaining to free support services



68

28


(iii) Others (net)



11

3


Net profit/(loss) after tax as per Ind-AS



370

(3,300)

5 The face value and fair value of FCCBs outstanding as at December 31, 2016 are as follows:













Face value

Fair value


Particulars


US$ Million

Rs in Lakhs

US$ Million

Rs in Lakhs


FCCBs I


1.00

679

1.35

917


FCCBs II


1.40

951

1.99

1,352


FCCBs III


3.60

2,445

3.43

2,330


Total


6.00

4,075

6.77

4,599

The FCCB holders in their respective meetings have approved the deferral of aggregate interest of US$ 0.73 Million i.e. Rs 495 Lakhs in respect of outstanding FCCBs III with face value of US$ 3.60 Million for the period July 6, 2012 to January 5, 2016 till redemption date of the bonds, being July 07, 2017.

7 The Company had remitted the withholding taxes on interest on FCCBs III in accordance with the provisions of the Income Tax Act, 1961 amounting to Rs 1,025 Lakhs pertaining to FCCBs III which have been converted into equity shares of the Company. Pursuant to such conversion, the interest accrued but not due is considered no longer payable and the management basis expert advice, is of the view that the withholding taxes paid by the Company in respect of the aforesaid interest, are recoverable from income tax department and/or are adjustable against its other withholding taxes obligations. Accordingly, the Company has revised the returns of withholding taxes and adjusted withholding taxes of Rs 377 Lakhs during the quarter ended December 31, 2016 ( quarter ended September 30, 2016 and December 31, 2015 amounting to Rs 250 Lakhs and Rs Nil, respectively and that for the nine months ended December 31, 2016 and December 31, 2015 amounting to Rs 832 Lakhs and Rs Nil, respectively.) on salary, professional services and others by write back of withholding taxes on interest on FCCBs paid earlier, and such write back is included under other income.


9 During the year ended March 31, 2016, the Company assessed the carrying value of goodwill relating to its investment in the subsidiary viz. Subex (UK) Limited, amounting to Rs 67,036 Lakhs. Based on the future operational plan, projected cash flows and the valuation carried out by an external valuer, the management was of the view that, the aforesaid carrying value of goodwill as at March 31, 2016 relating to its investment in the said subsidiary was appropriate. There is no change in the management's assessment as regards aforementioned carrying value of goodwill as at December 31, 2016.

10 Employee benefits expenses for the quarters ended December 31, 2016, September 30, 2016 and December 31, 2015 is net of reversal of provision no longer required, in respect of employee incentives, amounting to Rs Nil, Rs Nil and Rs 420 Lakhs, respectively and that for the nine months ended December 31, 2016 and December 31, 2015 amounting to Rs Nil and Rs 873 Lakhs, respectively.

11 The Company is engaged in the business of software products and related services. These, in the context of Ind-AS 108 on Operating Segments Reporting are considered to constitute one segment and hence the Company has not made any additional segment disclosures.

12 Previous period figures have been regrouped/ reclassified, wherever necessary to confirm to current period's classification.

13 Pursuant to Regulation 33 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, the Company has opted to publish the consolidated financial results. The standalone financial results, however, are being made available to the Stock Exchanges where the securities of the Company are listed and are also being posted on the Company's website www.subex.com.

Mumbai

Surjeet Singh

Date: February 03, 2017

Managing Director & CEO


For further details on the results, please visit our website: www.subex.com


This information is provided by RNS
The company news service from the London Stock Exchange
END
QRTBGGDDIXGBGRX

Recent news on Subex

See all news